Previous close | 6.69 |
Open | 6.34 |
Bid | 6.36 x 31000 |
Ask | 6.52 x 31000 |
Day's range | 6.34 - 6.34 |
52-week range | 5.55 - 9.82 |
Volume | |
Avg. volume | 53 |
Market cap | 2.325B |
Beta (5Y monthly) | 0.77 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 10 Nov 2010 |
1y target est | N/A |
Trading resumes in:
Approval Represents an Important Breakthrough in One of the Largest Medical Aesthetics Markets (*CORRECTION to the release that was posted earlier on January 18, 2024: The TR-4 Return Padisapproved for use by the U.S. Food & Drug Administration (as ...
Approval Represents an Important Breakthrough in One of the Largest Medical Aesthetics Markets LAVAL, QC / ACCESSWIRE / January 18, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and Solta Medical, a global leader in the medical aesthetics ...